tiprankstipranks
Advertisement
Advertisement

XBIO Stock Latest News

Xenetic reports FY25 EPS ($1.58) vs. ($2.57) last year
The FlyXenetic reports FY25 EPS ($1.58) vs. ($2.57) last year
15d ago
XBIO
Xenetic Biosciences faces ongoing delays in annual meeting
PremiumCompany Announcements
Xenetic Biosciences faces ongoing delays in annual meeting
3M ago
8K
XBIO
Xenetic Biosciences Adjourns 2025 Annual Meeting
PremiumCompany Announcements
Xenetic Biosciences Adjourns 2025 Annual Meeting
4M ago
8K
XBIO
Xenetic extends R&D collaboration with The Scripps Research Institute
PremiumThe Fly
Xenetic extends R&D collaboration with The Scripps Research Institute
4M ago
XBIO
Xenetic Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Xenetic Biosciences Reports Q3 2025 Financial Results
4M ago
XBIO
Xenetic reports Q3 EPS (33c) vs. (28c) last year
PremiumThe FlyXenetic reports Q3 EPS (33c) vs. (28c) last year
4M ago
XBIO
XBIO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
XBIO Upcoming Earnings Report: What to Expect?
5M ago
XBIO
Xenetic Biosciences Announces Public Offering Pricing
Premium
Company Announcements
Xenetic Biosciences Announces Public Offering Pricing
5M ago
8K
XBIO
Xenetic Biosciences trading resumes
PremiumThe Fly
Xenetic Biosciences trading resumes
6M ago
XBIO
Xenetic Biosciences trading halted, volatility trading pause
PremiumThe Fly
Xenetic Biosciences trading halted, volatility trading pause
6M ago
XBIO
Xenetic 735,000 share Spot Secondary priced at $6.12
PremiumThe Fly
Xenetic 735,000 share Spot Secondary priced at $6.12
6M ago
XBIO
Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?
PremiumMarket News
Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today?
6M ago
UPC
ACXP
Xenetic reports Q2 EPS (45c) vs. (83c) last year
PremiumThe FlyXenetic reports Q2 EPS (45c) vs. (83c) last year
8M ago
XBIO
Xenetic Biosciences Reports Improved Financial Performance
Premium
Company Announcements
Xenetic Biosciences Reports Improved Financial Performance
8M ago
XBIO
Is XBIO a Buy, Before Earnings?
Premium
Pre-Earnings
Is XBIO a Buy, Before Earnings?
8M ago
XBIO
Xenetic says PeriNess enters clinical study agreement for DNase Platform
PremiumThe Fly
Xenetic says PeriNess enters clinical study agreement for DNase Platform
8M ago
XBIO
Xenetic expands collaboration with The Scripps Research Institute
PremiumThe Fly
Xenetic expands collaboration with The Scripps Research Institute
8M ago
XBIO
Xenetic says PeriNess reports Bnei Zion Medical Center commences patient dosing
PremiumThe Fly
Xenetic says PeriNess reports Bnei Zion Medical Center commences patient dosing
9M ago
XBIO
Xenetic Biosciences Reports Improved Q1 2025 Results
PremiumCompany Announcements
Xenetic Biosciences Reports Improved Q1 2025 Results
10M ago
XBIO
Xenetic reports Q1 EPS (59c) vs. (78c) last year
PremiumThe FlyXenetic reports Q1 EPS (59c) vs. (78c) last year
11M ago
XBIO
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
Premium
The Fly
Xenetic partner PeriNess enters clinical study agreement for XBIO-015
1y ago
XBIO
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
Premium
The Fly
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
1y ago
XBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >